跳至主要内容
临床试验/ACTRN12605000623695
ACTRN12605000623695已完成不适用

Does home based humidification treatment reduce exacerbation frequency for people with COPD and bronchiectasis?

Fisher & Paykel Healthcare0 个研究点目标入组 110 人开始时间: 2005年10月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
20 Years 至 ot stated(—)
性别
All

入选标准

  • COPD; FEV1<70% and FEV1/FVC ratio <70%, and, > 2 exacerbation over the last 12 months, and > 5mL daily sputum production. Bronchiectasis; diagnosis of bronchiectasis confirmed by CT, and, > 2 exacerbation over the last 12 months.
  • All subjects were recruited when stable with no sign of an exacerbation for at least 4 weeks.

排除标准

  • Patients with significant comorbidity, bronchiectasis associated with cystic fibrosis or hypo-gammaglobulinemia were excluded.

研究者

相似试验